Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

Neuroprotective effects of HU-211 in soman-treated rats

Nov. 17, 1998

PARAGON A establishes effective dose of lamifiban in unstable angina

Nov. 17, 1998

Excellent results obtained during IVF procedures incorporating ganirelix acetate

Nov. 17, 1998

NIH sponsors clinical study of novel antiprogestin CDB-2914

Nov. 17, 1998

GPI-6150: data provide further support for development as a treatment for stroke

Nov. 17, 1998

Multiple preclinical and phase I study results presented for AIT-082 at neuroscience meeting

Nov. 17, 1998

Asta Medica focuses efforts on development of GnRH antagonist for enhancing fertility

Nov. 17, 1998

Oral bisphosphonate effectively treats, prevents corticosteroid-induced bone loss and fractures

Nov. 17, 1998

Amgen evaluates novel TNF-targeted immunotherapy in patients with active RA

Nov. 17, 1998

Stromelysin inhibitor Bay-12-9566 enters clinical testing for a second indication

Nov. 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...